Rapid Nutrition (ALRPD) H2 2024 earnings summary

Executive summary

• Focused on global expansion in health and wellness, leveraging evidence-based nutrition and advanced technology.

• Strategic investments in China, new product launches, and restructuring of flagship brands to drive future growth.

• Transitioned to a direct-to-consumer model and expanded subscription offerings, especially in the US and China.

Financial highlights

• Revenue declined to $917,044 from $1,655,285 year-over-year due to planned restructuring.

• Gross profit fell to $482,092 from $817,585; operating loss widened to $2,904,243 from $2,155,176.

• Administrative expenses reduced to $1,694,537 from $2,424,786, reflecting cost discipline.

• Inventory rose 93% to $334,298, and trade receivables increased 175% to $448,691, supporting expansion.

• Cash and equivalents at year-end were $95,809, down from $488,097.

Outlook and guidance

• Management expects sustained growth in 2025, driven by new markets, product innovation, and expanded subscription models.

• Additional €1.5 million funding secured post-year-end to support innovation and expansion.

• Focus on scaling direct-to-consumer channels in UK, Europe, Australia, China, and the US.